First it was bookstores, then general retail, then cloud computing and now groceries. Amazon.com, Inc. AMZN 0.38% has targeted industry after industry and left a trail of obsolete victims in its wake. Even investors who want nothing to do with Amazon have been forced to keep up with what the company has planned next to make sure the companies they own won’t be Amazon’s next target.
Earlier this year, Amazon was reportedly considering entering the pharmacy industry. Amazon even hired a new management team to put together a pharmacy strategy. This week, new reports have surfaced that Amazon has been in discussions with pharmaceutical middlemen known as pharmacy benefits managers. The news has led some to speculate that Amazon may be planning some form of mail-order prescription drug business targeting uninsured customers and/or customers with high deductibles.
The reports certainly seem to have gotten the attention of shareholders of CVS Health Corp CVS 2.49%, Walgreens Boots Alliance Inc WBA 1.28% and other drug store stocks.
In fact, Amazon may have been in the back of the mind of drug store investors for a while. Even with the S&P 500 making steady new all-time highs in the past two years, both Walgreens and CVS haven’t made new highs since mid-2015. On the day Amazon announced its Whole Foods deal, Walgreens stock got whacked down from $82.56 to $78.44. After aggressive selling pressure this week, the stock remains trapped in nearly a two-year trading range between $74 and $87.
CVS also got hammered by the Whole Foods news, which sent shares plummeting from around $80 to $77 the day the news was announced. CVS stock has also been trapped within a range between $73 and $84 throughout all of 2017.
Drug store traders seem to be mostly treading water for now, with one eye on Amazon and another eye on healthcare reform. News on either front could be…
Click here to continue reading
Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!
